Alle verbonden artikelen

Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells.

Auteurs : Najar M, Raicevic G, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L
Jaar : 2016
Journal : Cytotherapy
Volume : 18
Pagina's : 160-71

Metastatic breast cancer: The Odyssey of personalization.

Auteurs : Sonnenblick A, Pondé N, Piccart-Gebhart M
Jaar : 2016
Journal : Mol oncol
Volume : 10(8)
Pagina's : 1147-59

Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.

Auteurs : Benson C, Ray-Coquard I, Sleijfer S, Litière S, Blay JY, Le Cesne A, Papai Z, Judson I, Schöffski P, Chawla S, Gil T, Piperno-Neumann S, Marréaud S, Dewji MR, van der Graaf WT
Jaar : 2016
Journal : Gynecol Oncol
Volume : 142(1)
Pagina's : 89-94

Targeted adjuvant therapy in breast cancer.

Auteurs : Zardavas D, Tryfonidis K, Goulioti T, Piccart-Gebhart M
Jaar : 2016
Journal : Expert Rev Anticancer Ther
Volume : 16(12)
Pagina's : 1263-75

RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors.

Auteurs : Loi S, Dushyanthen S, Beavis PA, Salgado R, Denkert C, Savas P, Combs S, Rimm DL, Giltnane JM, Estrada MV, Sanchez V, Sanders M, Cook RS, Pilkinton MA, Mallal SA, Wang K, Miller VA, Stephens PJ, Yelensky R, Doimi FD, Gomez H, Ryzhov SV, Darcy PK, Arteaga CL, Balko JM
Jaar : 2016
Journal : Clin Cancer Res
Volume : 22(6)
Pagina's : 1499-509

Endocrine treatment in breast cancer: Cure, resistance and beyond.

Auteurs : Tryfonidis K, Zardavas D, Katzenellenbogen BS, Piccart-Gebhart M
Jaar : 2016
Journal : Cancer Treat Rev
Volume : 50
Pagina's : 68-81

Side-effects of checkpoint inhibitor-based combination therapy.

Auteurs : Kourie HR, Klastersky J
Jaar : 2016
Journal : Curr Opin Oncol
Volume : 28
Pagina's : 306.13

16ème Rencontre Eveline Markiewicz sur les urgences et complications sévères chez le patient cancéreux. Revue Médicale de Bruxelles, 37 (2) :123-125 : 2016.37(2)

Auteurs : Sculier JP
Jaar : 2016
Journal : Rev Med Brux
Volume : 37(2
Pagina's : 123-5

A Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early FDG PET-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer.

Auteurs : Lalami Y, Garcia C, Flamen P, Ameye L, Paesmans M, Awada A
Jaar : 2016
Journal : Head Neck
Volume : 38(3)
Pagina's : 347-54

Difficulties and limitations in conducting translational research in thoracic oncology. A practical example.

Auteurs : Meert AP, Ameye L, Leclercq N, Paesmans M, Remmelink M, Sculier JP, Berghmans T
Jaar : 2016
Journal : Rev Mal Respir
Volume : 33(7)
Pagina's : 594-9

Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials.

Auteurs : Ghislain I, Zikos E, Coens C, Quinten C, Balta V, Tryfonidis K, Piccart-Gebhart M, Zardavas D, Nagele E, Bjelic-Radisic V, Cardoso F, Sprangers MA, Velikova G, Bottomley A
Jaar : 2016
Journal : Lancet Oncol
Volume : 17
Pagina's : e294-304

The Glasgow inflammatory score and lung cancer: A predictor of admissions to emergency units].

Auteurs : Gorham J, Ameye L, Paesmans M, Berghmans T, Sculier JP, Meert AP
Jaar : 2016
Journal : Rev Mal Respir
Volume : 33(9)
Pagina's : 759-65

Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy.

Auteurs : Hoefkens F, Dehandschutter C, Somville J, Meijnders P, Van Gestel D
Jaar : 2016
Journal : Radiat Oncol
Volume : 11
Pagina's : 136

Time trends in axilla management among early breast cancer patients: Persisting major variation in clinical practice across European centers.

Auteurs : Gondos A, Jansen L, Heil J, Schneeweiss A, Voogd AC, Frisell J, Fredriksson I, Johansson U, Tvedskov TF, Jensen MB, Balslev E, Hartmann-Johnsen OJ, Sant M, Baili P, Agresti R, van de Velde T, Broeks A, Nogaret JM, Bourgeois P, Moreau M, Mátrai Z, Sávolt Á, Nagy P, Kásler M, Schrotz-King P, Ulrich C, Brenner H
Jaar : 2016
Journal : Acta oncol (Stockholm)
Volume : 55(6)
Pagina's : 712-9

Reply to the letter to the editor 'Utilisation of the ESMO-MCBS in practice of HTA' by Wild et al.

Auteurs : Cherny NI, Sullivan R, Dafni U, Bogaerts J, Kerst JM, Zielinski C, Piccart-Gebhart M, de Vries EG
Jaar : 2016
Journal : Ann Oncol
Volume : 27(11)
Pagina's : 2136-7

The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013."

Auteurs : Rapoport B, Klastersky J, Raftopoulos H, Freifeld A, Aoun M, Zinner SH, Rolston KV
Jaar : 2016
Journal : Support Care Cancer
Volume : 24(7)
Pagina's : 2819-26

Rôle de corticostéroïdes dans le cancer de la prostate. Effet bénéfique ou néfaste ?

Auteurs : Martinez C, Sideris S, Roumeguere T, Van Velthoven R, Awada A, Costante G, Gil T
Jaar : 2016
Journal : Onco-Hémato
Volume : -
Pagina's : -

p53 Reactivation by PRIMA-1 Met (APR-246) sensitises V600E/K BRAF melanoma to vemurafenib.

Auteurs : Krayem M, Journe F, Wiedig M, Morandini R, Najem A, Sales F, Van Kempen LC, Sibille C, Awada A, Marine JC, Ghanem G
Jaar : 2016
Journal : Eur J Cancer
Volume : 55
Pagina's : 98-110

Do refined consensus guidelines improve the uniformity of clinical target volume delineation for rectal cancer? Results of a national review project.

Auteurs : Joye I, Macq G, Vaes E, Roels S, Lambrecht M, Pelgrims A, Bussels B, Vancleef A, Stellamans K, Scalliet P, Weytjens R, Christian N, Boulanger AS, Donnay L, Van Brussel S, Moretti L, Van den Bergh L, Van Eycken E, Debucquoy A, Haustermans K
Jaar : 2016
Journal : Radiother Oncol
Volume : 120(2)
Pagina's : 202-6

Nasopharyngeal adenoid cystic carcinoma, a rare but highly challenging disease with unmet therapeutic needs: A case-report and review of the literature].

Auteurs : Afani L, Errihani H, Benchafai I, Lalami Y
Jaar : 2016
Journal : Cancer Radiother
Volume : 20(5)
Pagina's : 400-4